Subhayan Chattopadhyay

19PUBLICATIONS
44CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 19, 2026
Combined ATR and mitotic inhibition is effective against MYCN-amplified neuroblastoma.

|Jun 12, 2023
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development.

Jurica Baranasic, Yasmeen Niazi, Subhayan Chattopadhyay

|May 04, 2023
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.

Bahar Rastegar, Natalie Andersson, Alexandra Petersson

|Aug 03, 2021
Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST.

Subhayan Chattopadhyay, Jenny Karlsson, Anders Valind

|Mar 12, 2020
Second Primary Cancers in Melanoma Patients Critically Shorten Survival.

Guoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist

|Dec 20, 2019
Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer.

S Chattopadhyay, G Zheng, A Hemminki

Pageof 4

Frequent Collaborators

7 joint publications

Guoqiao Zheng

6 joint publications

Richard S Houlston

4 joint publications

Amit Sud

4 joint publications

Hauke Thomsen